Current Roles

Employees:
17
Revenue:
$3.4M
About
Bexson Biomedical is developing non-opioid therapies for pain management. Our goal is to provide therapies that provide relief to patients and reduce the rates of opioid addiction.
Bexson Biomedical / Ketamine Reformulation Development Address
856 Chelham Way
Santa Barbara, CA
United States
Bexson Biomedical / Ketamine Reformulation Development Email

Past Companies

Bexson BiomedicalVice President Of Quality
AmgenExecutive Director Final Product Technologies Quality
SHL Group (Scandinavian Health Limited)VP Of Regulatory and Compliance

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.